TDW GROUP has a total of 27 patent applications. It increased the IP activity by 150.0%. Its first patent ever was published in 2014. It filed its patents most often in EPO (European Patent Office), Taiwan and China. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are TESTI ROBERTO, HORIZON PHARMA RHEUMATOLOGY LLC and Biostrategies LC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | Taiwan | 5 | |
#3 | China | 4 | |
#4 | WIPO (World Intellectual Property Organization) | 4 | |
#5 | United States | 3 | |
#6 | Australia | 2 | |
#7 | Singapore | 2 | |
#8 | Japan | 1 | |
#9 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks | |
#4 | Environmental technology | |
#5 | Measurement |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Enzymes | |
#3 | Medical preparations | |
#4 | Therapeutic chemical compounds | |
#5 | Peptides | |
#6 | Climate change adaptation technologies | |
#7 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Thomson James A | 19 |
#2 | Almassy Robert | 18 |
#3 | He Wei | 14 |
#4 | Guo Yunyun | 12 |
#5 | Showalter Richard E | 12 |
#6 | Wu Bor-Wen | 11 |
#7 | Chen Li-Chang | 7 |
#8 | He Jiaojuan | 7 |
#9 | Lee Yang | 7 |
#10 | Sisson Wes | 7 |
Publication | Filing date | Title |
---|---|---|
CN110461354A | Protein conjugate | |
TW201625295A | Arginine deiminase with reduced cross-reactivity toward adi-peg 20 antibodies for cancer treatment | |
TW201619202A | Antibodies to argininosuccinate synthase and related methods | |
TW201634058A | Engineered chimeric pegylated adi and methods of use | |
CN106794229A | Engineering chimeric Pegylation ADI and application method | |
TW201534727A | Arginine deiminase with reduced cross-reactivity toward adi-peg 20 antibodies for cancer treatment | |
AU2014236653A1 | Arginine deiminase with reduced cross-reactivity toward ADI - PEG 20 antibodies for cancer treatment |